Academic Journals Database
Disseminating quality controlled scientific knowledge

5-AZACYTIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA: CASE REPORT AND REVIEW OF LITERATURE

ADD TO MY LIST
 
Author(s): Mariangela Greco | Marianna Criscuolo | Luana Fianchi | Livio Pagano | Maria Teresa Voso

Journal: Mediterranean Journal of Hematology and Infectious Diseases
ISSN 2035-3006

Volume: 3;
Issue: 1;
Start page: e2011011;
Date: 2011;
Original page

Keywords: CMML | 5-azacytidine

ABSTRACT
Hypomethylating drugs are useful in the management of Myelodysplastic syndromes, but there are only few reports on chronic myelomonocycitic (CMML) leukemia patients. We describe our experience in 3 CMML patients treated with azacitidine. Two patients obtained partial response after 4 treatment cycles with only minor toxicity and are in continuous partial response, with stable peripheral blood counts, at 29 and 30 cycles from treatment start.
Why do you need a reservation system?      Save time & money - Smart Internet Solutions